Sinopharm
1099.HK
#2681
Rank
โ‚น634.09 B
Marketcap
โ‚น203.19
Share price
1.89%
Change (1 day)
0.34%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2024 (TTM): โ‚น5.31

According to Sinopharm's latest financial reports the company's current EPS (TTM) is โ‚น31.16. In 2025 the company made an earnings per share (EPS) of โ‚น31.16 an increase over its 2024 EPS that were of โ‚น29.48.

EPS history for Sinopharm from 2006 to 2024

Annual EPS

Year EPS Change
2025โ‚น31.165.7%
2024โ‚น29.48-24.52%
2023โ‚น39.063.65%
2022โ‚น37.681.3%
2021โ‚น37.2010.33%
2020โ‚น33.7217.26%
2019โ‚น28.755.44%
2018โ‚น27.27-0.87%
2017โ‚น27.5119.44%
2016โ‚น23.0315.3%
2015โ‚น19.9817.06%
2014โ‚น17.0721.9%
2013โ‚น14.0011.82%
2012โ‚น12.5225.24%
2011โ‚น10.0031.02%
2010โ‚น7.633.3%
2009โ‚น7.3946.85%
2008โ‚น5.0367.57%
2007โ‚น3.00310.24%
2006โ‚น0.73